SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-017586
Filing Date
2022-11-14
Accepted
2022-11-14 07:50:45
Documents
57
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220930x10q.htm   iXBRL 10-Q 1994433
2 EX-31.1 tmb-20220930xex31d1.htm EX-31.1 9566
3 EX-31.2 tmb-20220930xex31d2.htm EX-31.2 9587
4 EX-32.1 tmb-20220930xex32d1.htm EX-32.1 5430
5 EX-32.2 tmb-20220930xex32d2.htm EX-32.2 5466
  Complete submission text file 0001558370-22-017586.txt   6889508

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20220930.xsd EX-101.SCH 30958
7 EX-101.CAL tmb-20220930_cal.xml EX-101.CAL 47011
8 EX-101.DEF tmb-20220930_def.xml EX-101.DEF 122160
9 EX-101.LAB tmb-20220930_lab.xml EX-101.LAB 299274
10 EX-101.PRE tmb-20220930_pre.xml EX-101.PRE 249444
51 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220930x10q_htm.xml XML 1357459
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40544 | Film No.: 221380354
SIC: 2834 Pharmaceutical Preparations